Quote from Softgiant:
thanks no heat, your advice is exactly what my instinct and thoughts are telling me but wanted to hear some other points of view.
I have done well off the financials over the past year, and i think it may be time for me to look to anotehr sector for more modest and safe gains
Biotech is a great area, especially the diabetes realm. GIVN might be an interesting Israeli play on colonoscopies. I personally won't be buying GIVN since I don't like its financials. They have revenues of $635 on each unit and only $39 operating profit per unit. They could make $1,400 in the private market (assuming they could get $2,000 for their units). They are too beholden to the European market, but they have some great features and if approved in the US or gets traction in certain Asian economies, it could skyrocket. They have 223,000 units that they sell.
I just made a major purchase on Skyworks Solutions (SWKS); the CEO seems like a very honest man and if I lose money in it, I can afford to take the hit (the absolute risk with 2.25 leverage is 3.5% of my portfolio).
The six sectors I really like are:
1) Biotech - particularly diabetes, oncology divisions, and kidney troubles. Look for high-profit margin areas (flu and HMO isn't an interest of mine except for maybe a value investment play).
2) Regional Banks/Financials - these banks have not had the same run-up as larger banks. If you are going into the large bank realm, I love WFC, JPM, TROW (brokerage), CB (insurance), or NYX. I might also want to look in the pawn shop arena if you believe in a double-dip recession.
3) Tech - this is a very interesting sector that hasn't done well since the beginning of the year.
4) Telecom - these have not taken off and did well from November of 2008 to March of 2009.
5) Consumer Staples - if you think the market is getting toppy.
6) Chemicals - these are great if you are looking for something not correlated with the market. DD, MON, and PG&E are examples in this segment.